| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC0005 |
| Trial ID | NCT00012207 |
| Disease | Lymphoma |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD20 CAR-T cells |
| HLA | MHC-independent |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I Study To Evaluate The Safety Of Cellular Immunotherapy Using Genetically Modified Autologous Cd20-Specific Cd8+ T Cell Clones For Patients With Relapsed Cd20+ Indolent Lymphomas |
| Year | 2001 |
| Country | United States |
| Company sponsor | Fred Hutchinson Cancer Center |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||||||||
|
|||||||||||||||||||